target menu
... / ... / Diagnostiek / Publicaties LMI
 

Publicaties LMI

LMI_logo_RGB

 Publicaties 2016

Dik WA, Paridaens D, Dalm VASH, Peeters RP, Van Hagen PM.
Graves' orbitopathie: pathogenese en behandeling.
In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afdeling Immunologie, Erasmus MC; 2016. p. 11-28.

Schreurs MWJ, Titulaer MJ.
Diagnostiek van neuronale antistoffen bij auto-immuun encefalitis.
In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afdeling Immunologie, Erasmus MC; 2016. p. 39-53.

Dalm VASH, Van der Burg M, Van Hagen PM.
Humorale immuundeficiënties: kliniek en diagnostiek.
In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afd. Immunologie, Erasmus MC; 2016. p. 57-73.

Van der Burg M, IJspeert H, Driessen GJA.
T-cel deficiënties.
In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afd. Immunologie, Erasmus MC; 2016. p. 87-94.

Van der Velden VHJ, Theunissen PMJ, Van Der Sluijs-Gelling A, De Haas V, Van Dongen JJM, Consortium nhE.
Detectie van minimale restziekte in acute lymfatische leukemie.
In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afd. Immunologie, Erasmus MC; 2016. p. 99-116.

Langerak AW, Dik WA, Lu L, Heezen KC, Swagemakers SMA, Van der Velden VHJ, Schilperoord-Vermeulen J, Van der Spek PJ, Rothova A, Van Dongen JJM, De Hoog J.
Diagnostiek van intra-oculair lymfoom: gecombineerde rol voor flowcytometrie en proteomics.
In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afd. Immunologie, Erasmus MC; 2016. p. 117-30.

IJspeert H, Van Schouwenburg PA, Van der Burg M.
Strategieën voor repertoire analyse.
In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afd. Immunologie, Erasmus MC; 2016. p. 161-76.

Van Dongen JJM, Teodosio C, Van den Bossche WBL, Berkowska M, Perez M, Almeida J, Orfao A.
Nieuwe ontwikkelingen in immuunmonitoring: flowcytometrische analyse van differentiatie-, maturatie-, en activatieprocessen.
In: Van Dongen JJM, Brooimans RA, Dik WA, Langerak AW, Schreurs MWJ, Van der Velden VHJ, editors. Nieuwe ontwikkelingen in de Medische Immunologie. Rotterdam: Laboratorium Medische Immunologie, afd. Immunologie, Erasmus MC; 2016. p. 177-83.

Denys B, Van der Velden VHJ, Boeckx N.
Hematologische maligniteiten – leukemie.
In: Bossuyt X, editor. Wegwijs in laboratorium-diagnose. Leuven: Acco; 2016. p. 101-14.

van Dongen JJM, Langerak AW, Kroese FGM.
Vorming en expressie van antigeenreceptoren op T- en B-lymfocyten.
In: Rijkers GT, Kroese FGM, Kallenberg CGM, Derksen RHWM, editors. Leerboek immunologie. Houten: Bohn, Stafleu, van Loghum; 2016. p. 103-26.

van Gent DC, IJspeert H, van der Burg M.
Nonhomologous end-joining.  DNA Replication, Recombination, and Repair: Molecular Mechanisms and Pathology.
Springer Japan; 2016. p. 341-62.

Theunissen P, Mejstrikova E, Sedek L, Van der Sluijs A, Gaipa G, Bartels M, Sobral de Costa E, Kotrova M, Novakova M, Sonneveld E, Baracchi C, Bonaccorso P, Oliviera E, te Marvelde JG, Szczepanski T, Lhermitte L, Hrusak O, Lecrevisse Q, Grigore GE, Fronkova E, Trka J, Bruggemann M, Orfao A, Van Dongen JJM, Van der Velden VHJ, Consortium obotE.
Standardized next-generation flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia.
In: Van Dongen JJM, editor. 5th ESLHO Symposium New Developments in the ESLHO Networks. Leiden 2016. p. 37-43.

Akar HH, Patiroglu T, Hershfield M, van der Burg M.
Combined immunodeficiencies: twenty years experience from a single center in Turkey.
Cent Eur J Immunol. 2016;41(1):107-15.

Berk KA, Oudshoorn TP, Verhoeven AJM, Mulder MT, Roks AJM, Dik WA, Timman R, Sijbrands EJG.
Diet-induced weight loss and markers of endothelial dysfunction and inflammation in treated patients with type 2 diabetes.
Clinical Nutrition ESPEN. 2016;15:101-6.

van Bezooijen JS, Balak DM, van Doorn MB, Looman CW, Schreurs MW, Koch BC, van Gelder T, Prens EP.
Combination Therapy of Etanercept and Fumarates versus Etanercept Monotherapy in Psoriasis: A Randomized Exploratory Study.
Dermatology. 2016;232(4):407-14.

van Bezooijen JS, Koch BC, van Doorn MB, Prens EP, van Gelder T, Schreurs MW.
Comparison of Three Assays to Quantify Infliximab, Adalimumab, and Etanercept Serum Concentrations.
Ther Drug Monit. 2016;38(4):432-8.

Brkic Z, van Bon L, Cossu M, van Helden-Meeuwsen CG, Vonk MC, Knaapen H, van den Berg W, Dalm VA, Van Daele PL, Severino A, Maria NI, Guillen S, Dik WA, Beretta L, Versnel MA, Radstake T.
The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis.
Ann Rheum Dis. 2016;75(8):1567-73.

Cantaert T, Schickel JN, Bannock JM, Ng YS, Massad C, Delmotte FR, Yamakawa N, Glauzy S, Chamberlain N, Kinnunen T, Menard L, Lavoie A, Walter JE, Notarangelo LD, Bruneau J, Al-Herz W, Kilic SS, Ochs HD, Cunningham-Rundles C, van der Burg M, Kuijpers TW, Kracker S, Kaneko H, Sekinaka Y, Nonoyama S, Durandy A, Meffre E.
Decreased somatic hypermutation induces an impaired peripheral B cell tolerance checkpoint.
J Clin Invest. 2016;126(11):4289-302.

van Coevorden-Hameete MH, Titulaer MJ, Schreurs MW, de Graaff E, Sillevis Smitt PA, Hoogenraad CC.
Detection and Characterization of Autoantibodies to Neuronal Cell-Surface Antigens in the Central Nervous System.
Front Mol Neurosci. 2016;9:37.

Damasceno D, Andres MP, van den Bossche WB, Flores-Montero J, de Bruin S, Teodosio C, van Dongen JJ, Orfao A, Almeida J.
Expression profile of novel cell surface molecules on different subsets of human peripheral blood antigen-presenting cells.
Clin Transl Immunology. 2016;5(9):e100.

van den Heuvel D, Jansen MA, Dik WA, Bouallouch-Charif H, Zhao D, van Kester KA, Smits-te Nijenhuis MA, Kolijn-Couwenberg MJ, Jaddoe VW, Arens R, van Dongen JJ, Moll HA, van Zelm MC.
Cytomegalovirus- and Epstein-Barr Virus-Induced T-Cell Expansions in Young Children Do Not Impair Naive T-cell Populations or Vaccination Responses: The Generation R Study.
J Infect Dis. 2016;213(2):233-42.

van der Valk JP, Schreurs MW, El Bouch R, Arends NJ, de Jong NW.
Mono-sensitisation to peanut component Ara h 6: a case series of five children and literature review.
Eur J Pediatr. 2016;175(9):1227-34.

van der Velden VH, de Launaij D, de Vries JF, de Haas V, Sonneveld E, Voerman JS, de Bie M, Revesz T, Avigad S, Yeoh AE, Swagemakers SM, Eckert C, Pieters R, van Dongen JJ.
New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B-cell precursor acute lymphoblastic leukaemia.
Br J Haematol. 2016;172(5):769-81.

Dik WA, Virakul S, van Steensel L.
Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.
Exp Eye Res. 2016;142:83-91.

Drexhage HA, Dik WA, Leenen PJ, Versnel MA.
The Immune Pathogenesis of Type 1 Diabetes: Not Only Thinking Outside the Cell but Also Outside the Islet and Out of the Box.
Diabetes. 2016;65(8):2130-3.

Driessen GJ, IJspeert H, Wentink M, Yntema HG, van Hagen PM, van Strien A, Bucciol G, Cogulu O, Trip M, Nillesen W, Peeters EA, Pico-Knijnenburg I, Barendregt BH, Rizzi M, van Dongen JJ, Kutukculer N, van der Burg M.
Increased PI3K/Akt activity and deregulated humoral immune response in human PTEN deficiency.
J Allergy Clin Immunol. 2016;138(6):1744-7 e5.

Esenboga S, Ayvaz DC, Cetinkaya PG, van der Burg M, Tezcan I.
An infant with ZAP-70 deficiency with disseminated mycobacterial disease.
J Clin Immunol. 2016;36(2):103-6.

Flores-Montero J, de Tute R, Paiva B, Perez JJ, Bottcher S, Wind H, Sanoja L, Puig N, Lecrevisse Q, Vidriales MB, van Dongen JJ, Orfao A.
Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma.
Cytometry B Clin Cytom. 2016;90(1):61-72.

de Haan N, Reiding KR, Driessen G, van der Burg M, Wuhrer M.
Changes in Healthy Human IgG Fc-Glycosylation after Birth and during Early Childhood.
J Proteome Res. 2016;15(6):1853-61.

Hoorn EJ, Taams NE, Hurskainen T, Salih M, Weening JJ, Jonkman MF, Pas HH, Schreurs MW.
Bullous Pemphigoid With a Dual Pattern of Glomerular Immune Complex Disease.
Am J Kidney Dis. 2016;67(2):302-6.

Huang L, Langerak AW, Baan CC, Litjens NH, Betjes MG.
Latency for cytomegalovirus impacts T cell ageing significantly in elderly end-stage renal disease patients.
Clin Exp Immunol. 2016;186(2):239-48.

IJspeert H, Rozmus J, Schwarz K, Warren RL, van Zessen D, Holt RA, Pico-Knijnenburg I, Simons E, Jerchel I, Wawer A, Lorenz M, Patiroglu T, Akar HH, Leite R, Verkaik NS, Stubbs AP, van Gent DC, van Dongen JJ, van der Burg M.
XLF deficiency results in reduced N-nucleotide addition during V(D)J recombination.
Blood. 2016;128(5):650-9.

IJspeert H, van Schouwenburg PA, van Zessen D, Pico-Knijnenburg I, Driessen GJ, Stubbs AP, van der Burg M.
Evaluation of the Antigen-Experienced B-Cell Receptor Repertoire in Healthy Children and Adults.
Front Immunol. 2016;7(OCT):410.

Janda A, Schwarz K, van der Burg M, Vach W, IJspeert H, Lorenz MR, Elgizouli M, Pieper K, Fisch P, Hagel J, Lorenzetti R, Seidl M, Roesler J, Hauck F, Traggiai E, Speckmann C, Rensing-Ehl A, Ehl S, Eibel H, Rizzi M.
Disturbed B-lymphocyte selection in autoimmune lymphoproliferative syndrome.
Blood. 2016;127(18):2193-202.

Jansen MA, van den Heuvel D, Bouthoorn SH, Jaddoe VW, Hooijkaas H, Raat H, Fraaij PL, van Zelm MC, Moll HA.
Determinants of Ethnic Differences in Cytomegalovirus, Epstein-Barr Virus, and Herpes Simplex Virus Type 1 Seroprevalence in Childhood.
J Pediatr. 2016;170:126-34 e1-6.

Jansen MA, van den Heuvel D, van der Zwet KV, Jaddoe VW, Hofman A, Escher JC, Fraaij PL, Hooijkaas H, van Zelm MC, Moll HA.
Herpesvirus Infections and Transglutaminase Type 2 Antibody Positivity in Childhood: The Generation R Study.
J Pediatr Gastroenterol Nutr. 2016;63(4):423-30.

Langerak AW.
Toward Standardization of Clonality Testing in Veterinary Medicine.
Vet Pathol. 2016;53(4):705-6.

Lilleker JB, Jones MS, Mohanraj R, van Sonderen A, Schreurs MW, de Bruijn MA, Sillevis Smitt PA, Titulaer MJ.
The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies.
Neurology. 2016;87(17):1848-9.

Ljungstrom V, Cortese D, Young E, Pandzic T, Mansouri L, Plevova K, Ntoufa S, Baliakas P, Clifford R, Sutton LA, Blakemore SJ, Stavroyianni N, Agathangelidis A, Rossi D, Hoglund M, Kotaskova J, Juliusson G, Belessi C, Chiorazzi N, Panagiotidis P, Langerak AW, Smedby KE, Oscier D, Gaidano G, Schuh A, Davi F, Pott C, Strefford JC, Trentin L, Pospisilova S, Ghia P, Stamatopoulos K, Sjoblom T, Rosenquist R.
Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.
Blood. 2016;127(8):1007-16.

Maria NI, van Helden-Meeuwsen CG, Brkic Z, Paulissen SM, Steenwijk EC, Dalm VA, van Daele PL, van Hagen MP, Kroese FG, van Roon JA, Harkin A, Dik WA, Drexhage HA, Lubberts E, Versnel MA.
Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3-Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon-Positive Primary Sjogren's Syndrome.
Arthritis Rheumatol. 2016;68(7):1688-99.

Muggen AF, Singh SP, Hendriks RW, Langerak AW.
Targeting Signaling Pathways in Chronic Lymphocytic Leukemia.
Curr Cancer Drug Targets. 2016;16(8):669-88.

Navrkalova V, Young E, Baliakas P, Radova L, Sutton LA, Plevova K, Mansouri L, Ljungstrom V, Ntoufa S, Davis Z, Juliusson G, Smedby KE, Belessi C, Panagiotidis P, Touloumenidou T, Davi F, Langerak AW, Ghia P, Strefford JC, Oscier D, Mayer J, Stamatopoulos K, Pospisilova S, Rosenquist R, Trbusek M.
ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres.
Haematologica. 2016;101(9):e369-73.

Novakova M, Zaliova M, Sukova M, Wlodarski M, Janda A, Fronkova E, Campr V, Lejhancova K, Zapletal O, Pospisilova D, Cerna Z, Kuhn T, Svec P, Pelkova V, Zemanova Z, Kerndrup G, van den Heuvel-Eibrink M, van der Velden V, Niemeyer C, Kalina T, Trka J, Stary J, Hrusak O, Mejstrikova E.
Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome.
Haematologica. 2016;101(6):707-16.

Paiva B, Cedena MT, Puig N, Arana P, Vidriales MB, Cordon L, Flores-Montero J, Gutierrez NC, Martin-Ramos ML, Martinez-Lopez J, Ocio EM, Hernandez MT, Teruel AI, Rosinol L, Echeveste MA, Martinez R, Gironella M, Oriol A, Cabrera C, Martin J, Bargay J, Encinas C, Gonzalez Y, Van Dongen JJ, Orfao A, Blade J, Mateos MV, Lahuerta JJ, San Miguel JF, Grupo Espanol de Mieloma/Programa para el Estudio de la Terapeutica en Hemopatias Malignas Cooperative Study G.
Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients.
Blood. 2016;127(25):3165-74.

Pieters R, de Groot-Kruseman H, Van der Velden V, Fiocco M, van den Berg H, de Bont E, Egeler RM, Hoogerbrugge P, Kaspers G, Van der Schoot E, De Haas V, Van Dongen J.
Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group.
J Clin Oncol. 2016;34(22):2591-601.

Pojero F, Flores-Montero J, Sanoja L, Perez JJ, Puig N, Paiva B, Bottcher S, van Dongen JJ, Orfao A, EuroFlow group.
Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases.
Cytometry B Clin Cytom. 2016;90(1):91-100.

Preijers FW, van der Velden VH, Preijers T, Brooimans RA, Marijt E, Homburg C, van Montfort K, Gratama JW, Section I, Molecular Cell Diagnostics of the Foundation for Quality Assessment in Medical L.
Fifteen years of external quality assessment in leukemia/lymphoma immunophenotyping in The Netherlands and Belgium: A way forward.
Cytometry B Clin Cytom. 2016;90(3):267-78.

Rietveld MJ, Schreurs MW, Gerth van Wijk R, van Daele PL, Hermans MA.
The Basophil Activation Test Is Not a Useful Screening Tool for Hymenoptera Venom-Related Anaphylaxis in Patients with Systemic Mastocytosis.
Int Arch Allergy Immunol. 2016;169(2):125-9.

Rother MB, Jensen K, van der Burg M, van de Bovenkamp FS, Kroek R, van IWF, van der Velden VH, Cupedo T, Olstad OK, van Dongen JJ, van Zelm MC.
Decreased IL7Ralpha and TdT expression underlie the skewed immunoglobulin repertoire of human B-cell precursors from fetal origin.
Sci Rep. 2016;6:33924.

Rother MB, Palstra RJ, Jhunjhunwala S, van Kester KA, van IJcken WF, Hendriks RW, van Dongen JJ, Murre C, van Zelm MC.
Nuclear positioning rather than contraction controls ordered rearrangements of immunoglobulin loci.
Nucleic Acids Res. 2016;44(1):175-86.

Rother MB, Schreurs MW, Kroek R, Bartol SJ, van Dongen JJ, van Zelm MC.
The Human Thymus Is Enriched for Autoreactive B Cells.
J Immunol. 2016;197(2):441-8.

Sandberg Y, Langerak AW, Lam KH, Rijneveld AW, van Lom K.
Leukocytose en huidafwijkingen: denk aan maligniteit; adulte T-celleukemie/-lymfoom.
Ned Tijdschr Geneeskd. 2016;160:A9866.

van Sonderen A, Arino H, Petit-Pedrol M, Leypoldt F, Kortvelyessy P, Wandinger KP, Lancaster E, Wirtz PW, Schreurs MW, Sillevis Smitt PA, Graus F, Dalmau J, Titulaer MJ.
The clinical spectrum of Caspr2 antibody-associated disease.
Neurology. 2016;87(5):521-8.

van Sonderen A, Schreurs MW, de Bruijn MA, Boukhrissi S, Nagtzaam MM, Hulsenboom ES, Enting RH, Thijs RD, Wirtz PW, Sillevis Smitt PA, Titulaer MJ.
The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies.
Neurology. 2016;86(18):1692-9.

van Sonderen A, Schreurs MW, de Bruijn MA, Sillevis Smitt PA, Titulaer MJ.
Antistofgeassocieerde encephalitis: handvatten voor diagnostiek en behandeling.
Ned Tijdschr Neurol Neurochir. 2016;117(2):78-88.

van Sonderen A, Schreurs MW, Wirtz PW, Sillevis Smitt PA, Titulaer MJ.
From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time.
Autoimmun Rev. 2016;15(10):970-4.

van Sonderen A, Thijs RD, Coenders EC, Jiskoot LC, Sanchez E, de Bruijn MA, van Coevorden-Hameete MH, Wirtz PW, Schreurs MW, Sillevis Smitt PA, Titulaer MJ.
Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up.
Neurology. 2016;87(14):1449-56.

Stetler-Stevenson M, Paiva B, Stoolman L, Lin P, Jorgensen JL, Orfao A, Van Dongen J, Rawstron AC.
Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition.
Cytometry B Clin Cytom. 2016;90(1):26-30.

Suratannon N, Yeetong P, Srichomthong C, Amarinthnukrowh P, Chatchatee P, Sosothikul D, van Hagen PM, van der Burg M, Wentink M, Driessen GJ, Suphapeetiporn K, Shotelersuk V.
Adaptive immune defects in a patient with leukocyte adhesion deficiency type III with a novel mutation in FERMT3.
Pediatr Allergy Immunol. 2016;27(2):214-7.

Sutton LA, Young E, Baliakas P, Hadzidimitriou A, Moysiadis T, Plevova K, Rossi D, Kminkova J, Stalika E, Pedersen LB, Malcikova J, Agathangelidis A, Davis Z, Mansouri L, Scarfo L, Boudjoghra M, Navarro A, Muggen AF, Yan XJ, Nguyen-Khac F, Larrayoz M, Panagiotidis P, Chiorazzi N, Niemann CU, Belessi C, Campo E, Strefford JC, Langerak AW, Oscier D, Gaidano G, Pospisilova S, Davi F, Ghia P, Stamatopoulos K, Rosenquist R, Eric tERIoCLL.
Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors.
Haematologica. 2016;101(8):959-67.

Ten Berge JC, van Rosmalen J, Vermeer J, Hellstrom C, Lindskog C, Nilsson P, Qundos U, Rothova A, Schreurs MW.
Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy.
PLoS One. 2016;11(12):e0167909.

Ten Berge JC, Schreurs MW, Vermeer J, Meester-Smoor MA, Rothova A.
Prevalence and clinical impact of antiretinal antibodies in uveitis.
Acta Ophthalmol. 2016;94(3):282-8.

van Veen M, Nijman RG, Zijlstra M, Dik WA, de Rijke YB, Moll HA, Neele M, Smit FJ, Oostenbrink R.
Neutrophil CD64 expression is not a useful biomarker for detecting serious bacterial infections in febrile children at the emergency department.
Infect Dis (Lond). 2016;48(5):331-7.

Veltman M, Stolarczyk M, Radzioch D, Wojewodka G, De Sanctis JB, Dik WA, Dzyubachyk O, Oravecz T, de Kleer I, Scholte BJ.
Correction of lung inflammation in a F508del CFTR murine cystic fibrosis model by the sphingosine-1-phosphate lyase inhibitor LX2931.
Am J Physiol Lung Cell Mol Physiol. 2016;311(5):L1000-L14.

Virakul S, Heutz JW, Dalm VA, Peeters RP, Paridaens D, van den Bosch WA, Hirankarn N, van Hagen PM, Dik WA.
Basic FGF and PDGF-BB synergistically stimulate hyaluronan and IL-6 production by orbital fibroblasts.
Mol Cell Endocrinol. 2016;433:94-104.

Virakul S, Phetsuksiri T, van Holten-Neelen C, Schrijver B, van Steensel L, Dalm VA, Paridaens D, van den Bosch WA, van Hagen PM, Dik WA.
Histamine induces NF-kappaB controlled cytokine secretion by orbital fibroblasts via histamine receptor type-1.
Exp Eye Res. 2016;147:85-93.

Wiekmeijer AS, Pike-Overzet K, IJspeert H, Brugman MH, Wolvers-Tettero IL, Lankester AC, Bredius RG, van Dongen JJ, Fibbe WE, Langerak AW, van der Burg M, Staal FJ.
Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells.
J Allergy Clin Immunol. 2016;137(2):517-26 e3.

Zondag TC, Rokx C, van Lom K, van den Berg AR, Sonneveld P, Dik WA, van Doornum GJ, Lam KH, van Laar JA.
Cytokine and viral load kinetics in human herpesvirus 8-associated multicentric Castleman's disease complicated by hemophagocytic lymphohistiocytosis.
Int J Hematol. 2016;103(4):469-72.